Brendan Haberle

Associate
Full contact info

Experience

Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche

August 6, 2022

Cooley advised Poseida Therapeutics, a clinical-stage biopharmaceutical company, on its strategic collaboration and license agreement with Roche. Lawyers Ken Krisko, Marya Postner, Bin Wang, Hajra Nashin and Brendan Haberle led the Cooley team advising Poseida. 

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Marya Postner
Partner, Palo Alto
Bin Wang
Special Counsel, Palo Alto
Hajra Nashin
Associate, San Diego
Brendan Haberle
Associate, San Diego
Edmond Lay
Associate, San Diego
Tom Coll
Partner, San Diego
Sharon Connaughton
Special Counsel, Washington DC
Jacqueline Grise
Partner, Washington DC
Amanda Pacheco
Associate, Palo Alto
Jeffrey J. Tolin
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Liza Cotter
Associate, Boston
Yasmin Roland
Associate, Brussels
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Maricel Mojares-Moore
Special Counsel, San Francisco

Related Practices & Industries

Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion

June 4, 2022

Cooley is advising Turning Point Therapeutics, a leading precision oncology company, on its definitive agreement to be acquired by global biopharmaceutical company Bristol Myers Squibb. Lawyers Barbara Borden, Rowook Park, Charles Bair, Lindsey O’Crump, Vivian Tsai and Melissa Meza are leading the Cooley team advising Turning Point Therapeutics.

Read more

Related contacts

Barbara Borden
Partner, San Diego
Rowook Park
Partner, San Diego
Charles Bair
Partner, San Diego
Lindsey O'Crump
Associate, Washington DC
Vivian Tsai
Associate, Los Angeles Santa Monica
Melissa Meza
Associate, San Diego
Kay Chandler
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Koji Fukumura
Partner, San Diego
Phil Mitchell
Partner, New York
David Navetta
Partner, Colorado
Todd Gluth
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Matthew D. Silverman
Special Counsel, San Diego
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Brendan Haberle
Associate, San Diego
Hajra Nashin
Associate, San Diego
Megan Drill
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Eileen Leman
Associate, Los Angeles Downtown
Daniel Gillon
Associate, San Diego
Wade Andrews
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Jennifer Shanley
Special Counsel, New York
Daniel Lac
Associate, San Diego

Related Practices & Industries

Poseida Therapeutics Enters Research Collaboration With Takeda to Develop Novel Gene Therapies

November 17, 2021

Cooley advised Poseida Therapeutics, a clinical-stage biopharmaceutical company, on its research collaboration and exclusive license agreement with Takeda Pharmaceutical Co. Lawyers Ken Krisko and Brendan Haberle led the Cooley team advising Poseida.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Brendan Haberle
Associate, San Diego
Jacqueline Grise
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Edmond Lay
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies

June 24, 2021

Cooley advised Shoreline Biosciences, a biotechnology company developing immunotherapies for cancer and other serious diseases, on its worldwide strategic collaboration with BeiGene to develop and commercialize a portfolio of natural killer-based cell therapeutics. Lawyers Charity Williams and Bin Wang led the Cooley team advising Shoreline.

Read more

Related contacts

Charity Williams
Partner, San Diego
Bin Wang
Special Counsel, Palo Alto
Aaron Pomeroy
Partner, Colorado
Guadalupe Sampedro
Partner, London
Brendan Haberle
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Edmond Lay
Associate, San Diego
Sarah Oliai
Associate, Washington DC
Bill Christiansen
Partner, Seattle

Related Practices & Industries

Shoreline Enters Partnership with Kite

Cooley advised Shoreline Biosciences, Inc., a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural killer (NK) and macrophage cellular immunotherapies derived from induced pluripotent stem cells (iPSC) for cancer and other serious diseases, in its strategic partnership with Kite, a Gilead Company (Nasdaq: GILD) to develop novel cell therapies across a variety of cancer targets. Under the terms of the agreement, Shoreline will receive an upfront payment and will be eligible to receive additional payments totaling over $2.3 billion as well as royalties based on achievement of certain development and commercial milestones.

Read more

Related contacts

Charity Williams
Partner, San Diego
Brendan Haberle
Associate, San Diego
Bin Wang
Special Counsel, Palo Alto

Related Practices & Industries